BC
MLTX icon

Birchview Capital’s MoonLake Immunotherapeutics MLTX Stock Holding History

Birchview Capital’s Portfolio MLTX Stock Details MLTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2025
Q2 		$378K Hold
8,000
– – 0.38% 46
2025
Q1 		$313K Buy
8,000
+4,000
+100% +$156K 0.27% 43
2024
Q4 		$217K Buy
+4,000
New +$217K 0.18% 56